tirzepatide tablet brand name Pills Tirzepatide (Mounjaro)-The new 'King Kong'
Description
10.12890/2024_004357 11 JaacksL

We prioritize a comprehensive approach, considering all potential benefits and risks while exploring alternative strategies tailored to your unique health profile and goals

This is the benefit of dual-receptor agonism

Rushing dose escalation increases side effects without proportionally increasing weight loss, and severe side effects can force dose reductions that effectively waste medication
.png)
References New England Journal of Medicine - Retatrutide Phase 2 Trial - Primary efficacy and safety data for retatrutide New England Journal of Medicine - SURMOUNT-1 Trial - Tirzepatide obesity trial results FDA - Zepbound (Tirzepatide) Approval - FDA approval information for tirzepatide ClinicalTrials.gov - Retatrutide Studies - Ongoing Phase 3 clinical trials ClinicalTrials.gov - Retatrutide Phase 3 trials Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice

The move is part of Lillys all hands on deck effort to ramp up supply of Zepbound and a similar drug for diabetes called Mounjaro amid widespread shortages, executive vice president Patrik Jonsson said in an interview
